Why Novavax Stock Is Rising Today

Shares of Novavax (NASDAQ: NVAX) were rising 2.8% as of 11:30 a.m. EDT on Tuesday after moving as much as 5% higher earlier in the day. The gains came after the U.S. Centers for Disease Control and Prevention (CDC) provided updated guidance that participants in Novavax's phase 3 clinical trial of its COVID-19 vaccine candidate who received two doses meet the criteria for being considered fully vaccinated.

The CDC was clear that its updated guidance doesn't imply in any way that Novavax's vaccine, NVX-CoV2373, has been authorized by the Food and Drug Administration or has been recommended by the CDC or its Advisory Committee on Immunization Practices. With this in mind, nothing has materially changed for Novavax.

Image source: Getty Images.

Source Fool.com